AUTHOR=Shen Shenghai , Zhang Li-Sheng 

TITLE=The regulation of antiviral innate immunity through non-m6A RNA modifications

JOURNAL=Frontiers in Immunology

VOLUME=14

YEAR=2023

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1286820

DOI=10.3389/fimmu.2023.1286820

ISSN=1664-3224

ABSTRACT=<p>The post-transcriptional RNA modifications impact the dynamic regulation of gene expression in diverse biological and physiological processes. Host RNA modifications play an indispensable role in regulating innate immune responses against virus infection in mammals. Meanwhile, the viral RNAs can be deposited with RNA modifications to interfere with the host immune responses. The <italic>N</italic><sup>6</sup>-methyladenosine (m<sup>6</sup>A) has boosted the recent emergence of RNA epigenetics, due to its high abundance and a transcriptome-wide widespread distribution in mammalian cells, proven to impact antiviral innate immunity. However, the other types of RNA modifications are also involved in regulating antiviral responses, and the functional roles of these non-m<sup>6</sup>A RNA modifications have not been comprehensively summarized. In this <italic>Review</italic>, we conclude the regulatory roles of 2’-<italic>O</italic>-methylation (Nm), 5-methylcytidine (m<sup>5</sup>C), adenosine-inosine editing (A-to-I editing), pseudouridine (Ψ), <italic>N</italic><sup>1</sup>-methyladenosine (m<sup>1</sup>A), <italic>N</italic><sup>7</sup>-methylguanosine (m<sup>7</sup>G), <italic>N</italic><sup>6</sup>,2’-<italic>O</italic>-dimethyladenosine (m<sup>6</sup>Am), and <italic>N</italic><sup>4</sup>-acetylcytidine (ac<sup>4</sup>C) in antiviral innate immunity. We provide a systematic introduction to the biogenesis and functions of these non-m<sup>6</sup>A RNA modifications in viral RNA, host RNA, and during virus-host interactions, emphasizing the biological functions of RNA modification regulators in antiviral responses. Furthermore, we discussed the recent research progress in the development of antiviral drugs through non-m<sup>6</sup>A RNA modifications. Collectively, this <italic>Review</italic> conveys knowledge and inspiration to researchers in multiple disciplines, highlighting the challenges and future directions in RNA epitranscriptome, immunology, and virology.</p>